LifeAire Systems’ Founder and CEO, Dr. Kathryn C. Worrilow, is speaking at InterPhex 2019 in New York City to raise visibility to the cytotoxic role that airborne volatile organic compounds, or VOCs, play in critical life sciences cleanroom environments—such as those supporting the living cell in gene cell and immunotherapy manufacturing.
Over 15 years of the study of the role airborne biological and chemical pathogens exert in epigenetic variation and molecular epidemiology have defined the airborne metrics necessary to support the culture of highly sensitive cellular products across all cell processing operations. The remediation of all airborne bacterial, viral, and chemical pathogens support a consistent living cell culture environment thereby optimizing critical metrics of cell potential, viability, loss, and clinical delivery.
Evidence will be presented to illustrate the negative impact of airborne chemical and viable particulate contaminants on cellular and regenerative medicine processes critical in healthcare and life science facilities. Current GMP metrics do not address cytotoxic levels of VOCs and viable particulates present in the processing space. An understanding of why it is critical to exceed GMP metrics to achieve optimal cell growth in life science facilities will be discussed.
LifeAire Systems’ patented, multi-stage air purification technologies allow such facilities to eliminate up to 99.99% of all known biological and chemical contaminants, thus comprehensively removing the toxic influence of airborne contaminants resulting in statistically significant increases in cellular metrics and the delivery of successful cellular products to the patient, thereby offering an improved level of patient care.
LifeAire is presenting in two key programs during the conference, a presentation on Tuesday morning and a panel discussion on Wednesday afternoon.